August 19, 2026
The 16th Australasian Cystic Fibrosis Conference, Geelong, Australia
Congratulations to Pramila Maniam, Research Officer in Dr David Reid’s team at QIMR Berghofer on receiving an award for her Oral Abstract Presentation at The 16th Australasia...
Read More
July 23, 2026
UK Trial Update: Operational and Recruitment
Headline of the Month: Appendix A2 recruitment can resume following Amendment 07 local implementation Appendix A1 Appendix A1 remains temporarily halted in the UK while Sponsor act...
Read More
June 18, 2026
Outcome from First Interim Analysis of 61 Participants after Short Intensive Therapy
“Finding the Optimal Regimen for Mycobacterium abscessus Treatment” (FORMaT) is a multi-site, international, investigator-led adaptive platform trial (APT) which aims to find the m...
Read More
April 24, 2026
FORMaT Trial’s First Interim Analysis
FORMaT Trial’s First Interim Analysis The FORMaT Trial has reached its target recruitment for the first interim analysis (61 participants recruited to the Intervention Progra...
Read More
November 24, 2025
Scientific Leadership & International Recognition
Scientific Leadership & International Recognition In 2025, the FORMaT team presented at multiple major international conferences, including: • The American Thoracic Society (AT...
Read More